Weighing Risks and Benefits of Liraglutide — The FDA’s Review of a New Antidiabetic Therapy

http://content.nejm.org/cgi/content/full/NEJMp1001578?query=TOC

FDA’s summary with regards to approval of liraglutide. Discussion of the potential benefits of improved glycaemic control whilst highlighting potentially serious safety concerns.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s